Patents for A61P 19 - Drugs for skeletal disorders (81,981)
02/2011
02/03/2011US20110028388 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
02/03/2011US20110028384 Rap variants for drug delivery
02/03/2011US20110027381 Treatment of osteoporosis
02/03/2011US20110027360 Pharmacokinetics of s-adenosylmethionine formulations
02/03/2011US20110027357 Compositions and methods for timed release of water-soluble nutritional supplements
02/03/2011US20110027342 S-adenosylmethionine formulations with enhanced bioavailability
02/03/2011US20110027332 Pliable medical device and method of use
02/03/2011US20110027301 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
02/03/2011US20110027281 Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
02/03/2011US20110027273 Immunotherapy of autoimmune disorders
02/03/2011US20110027269 14-3-3 Antagonists for the Prevention and Treatment of Arthritis
02/03/2011US20110027266 Humanized anti-CXCR5 antibodies, derivatives thereof and their use
02/03/2011US20110027257 Clottable concentrate of platelet growth factors and preparation method thereof
02/03/2011US20110027254 Compositions and methods for treating gaucher disease
02/03/2011US20110027237 Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
02/03/2011US20110027236 Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
02/03/2011US20110027222 Vaccine for the Treatment of Osteoarthritis
02/03/2011US20110027220 Interleukin-1 Conjugates and Uses Thereof
02/03/2011US20110023870 Intranasal Opioid Compositions, Delivery Devices and Methods of Using Same
02/03/2011CA2769633A1 Crystallization method and bioavailability
02/03/2011CA2769541A1 Compounds for treatment of inflammation
02/03/2011CA2769038A1 Antiangiogenic small molecules and methods of use
02/03/2011CA2769008A1 A pharmaceutical composition for an iontophoresis
02/03/2011CA2768527A1 Compounds - 801
02/03/2011CA2767899A1 Nitrogen-containing spiro-ring compound and medicinal use of same
02/02/2011EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors
02/02/2011EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF)
02/02/2011EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH)
02/02/2011EP2279753A2 Remodeling and glycoconjugation of peptides
02/02/2011EP2279744A2 ApoE mimetic agents
02/02/2011EP2279743A2 ApoE mimetic agents
02/02/2011EP2279742A2 Combinations for the treatment of immunoinflammatory disorders
02/02/2011EP2279741A2 Caprolactams and their use as anti-inflammatory agents
02/02/2011EP2278978A2 Non-hormonal steroid modulators of nf-kb for treatment of disease
02/02/2011EP2278966A2 Treatment with opioid antagonists and mtor inhibitors
02/02/2011EP1288205B1 Novel phenylalanine derivatives
02/02/2011EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil
02/02/2011CN101961478A Medicament for treating hyperosteogeny, rheumatism and rheumatoid diseases and preparation method thereof
02/02/2011CN101961477A Rheumatic bone ache medicine
02/02/2011CN101961467A Medicine for treating knee osteoarthritis and preparation method and application thereof
02/02/2011CN101961458A Oral medicament for treating osteonecrosis of femoral head
02/02/2011CN101961452A Method for preparing neck and waist rehabilitation medicinal plaster for treating osteoproliferation
02/02/2011CN101961448A Chinese medicament for treating diabetic gout
02/02/2011CN101961447A Novel preparation method, preparation and application of Chinese medicinal composition
02/02/2011CN101961446A Micropowder medicament for treating bone fractures and preparation method thereof
02/02/2011CN101961434A Rheumatic Xintong powder
02/02/2011CN101961431A Ointment for treating bone fractures
02/02/2011CN101961418A Double-controlled release, high-dosage and low-irritation capsaicin compound transdermal patch
02/02/2011CN101961406A Medicament for treating muscle and bone diseases causes by chronic infectious arthritis
02/02/2011CN101961370A Method for grinding resin medicinal materials and application
02/02/2011CN101961369A Formula of medicament for treating cervical spondylosis
02/02/2011CN101961364A Effective part of chicory or jerusalem artichoke and preparation thereof
02/02/2011CN101961344A Drug composite and application thereof
02/02/2011CN101961323A Self-emulsified resveratrol soft capsules
02/02/2011CN101961288A Leaf-like Chinese medicinal powder-combined portable massager
02/02/2011CN101961149A Special function nano-element Chinese medicinal water emergency fabric body-building clothes
02/02/2011CN101961104A Health care product or medicinal composition for strengthening bones and filling marrows and preparation method and application thereof
02/02/2011CN101623387B Pill for treating traumatic injury, new and old fracture and lumbar muscle strain
02/02/2011CN101574497B Chinese medicinal preparation for treating caput femoris aseptic ischemic necrosis
02/02/2011CN101513399B Application of T-2 toxin in the preparation of drugs for treating bone cancers and myeloproliferative disorder
02/02/2011CN101475576B Flavone lignose compound, and preparation and pharmaceutical use thereof
02/02/2011CN101468029B Difructose anhydride-containing composition and use thereof
02/02/2011CN101401888B Chinese medicament preparation for treating gout
02/02/2011CN101401833B Composition for preventing and/or treating osteoporosis
02/02/2011CN101380375B External traditional Chinese medicine preparation for treating bone and soft tissue injury and preparation method thereof
02/02/2011CN101317996B Traditional Chinese medicine emplastrum for rheumatism of muscles and bones
02/02/2011CN101143166B Medicine for swelling and relieving pain and its preparation method and application
02/02/2011CN101015682B Medicine composition with compact bone substance density improving function, preparing process and quality controlling means thereof
02/01/2011US7880000 N-(5-(1,1- dimethylethyl)-3- isoxazolyl)-4-methyl-3- ((3-(4-pyrimidinyl)-2- pyridinyl)amino)benzamide, used for treating breast cancer or rheumatoid arthritis
02/01/2011US7879966 pH-sensitive polymer
02/01/2011US7879881 Piperidinyl compounds that selectively bind integrins
02/01/2011US7879855 administering (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide, for the treatment of cancers of the colon, lung, ovary, and pancreas; anticarcinogenic agents
02/01/2011US7879817 Non-steroidal anti-inflammatory drugs bound to hyaluronic acid through a covalent bond via a spacer having a biodegradable region and disease-modifying anti-rheumatic drugs; salicylic acid, aspirin, mefenamic acid, tolfenamic acid; arthritis, suppress inflammation and pain; parenteral, topical
02/01/2011US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
02/01/2011US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same
02/01/2011US7879359 Compositions for preparing external carbon dioxide agents
02/01/2011US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders
02/01/2011US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction
02/01/2011US7879323 Antibodies to fibroblast growth factor-like polypeptides
02/01/2011CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers
02/01/2011CA2454804C Probiotic lactobacillus salivarius strains
02/01/2011CA2388369C Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
01/2011
01/27/2011WO2011011706A2 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents
01/27/2011WO2011011658A1 Adhesive complex coacervates and methods of making and using thereof
01/27/2011WO2011011513A1 Inhibition of pathological bone formation
01/27/2011WO2011011494A1 Imidazoazepinone compounds
01/27/2011WO2011010706A1 Fgf21 cis-element binding substance
01/27/2011WO2011010080A1 Inhibitor of inflammatory conditions
01/27/2011WO2010140162A3 A process for preparing stem cell based formulations
01/27/2011WO2010134100A3 Method for extraction of fractions containing pharmacologically active ingredients with less cytotoxicity from one or more plants
01/27/2011WO2010130830A3 Anti-sclerostin vhh and their use for treating bone diseases
01/27/2011US20110021766 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
01/27/2011US20110021747 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
01/27/2011US20110021636 Method for crystallization of 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-ethyl]-1,3-propanediol hydrochloride
01/27/2011US20110021614 Use of silymarin and silybin in the treatment of neural injury
01/27/2011US20110021612 Nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
01/27/2011US20110021598 Controlled release formulations
01/27/2011US20110021586 Phenyl-sulfamates as aromatase inhibitors
01/27/2011US20110021573 Antagonists of prostaglandin d2 receptors
01/27/2011US20110021560 Compositions And Methods For Regulating Chondrocyte Proliferation In Bone Disorders